Skip to main content

Clarusvisus/Getty Images/iStockphoto

Our roundup of Canadian small-caps of between $100-million and $2.5-billion in market capitalization making news and on the move today.

Thompson Creek Metals Company Inc. (TCM-T) says it has obtained "overwhelming shareholder approval" for the takeover of the company by Centerra Gold Inc. (CG-T).

It said 97 per cent of the votes cast by Thompson Creek shareholders were in favour of the deal.

Story continues below advertisement

Thompson Creek will become a wholly-owned subsidiary of Centerra, the company said in a release.


Goodfellow Inc. (GDL-T) says it has been granted a management cease trade order.

"This order was granted at the request of the corporation as an alternative to a cease trade order in relation to the delay in the filing of the corporation's interim financial report, interim management discussion and analysis and interim certificates for the quarter ended August 31, 2016," the company said in a release.


Uranium Participation Corp. (U-T) is raising $19.25-million in a bought deal with a syndicate of underwriters led by Cormark Securities Inc.

The agreement is for five million common shares at a price of $3.85 each. The stock closed at $3.94 on Tuesday.

Story continues below advertisement


Electrovaya Inc. (EFL-T) says it has signed a supply agreement with an unnamed global original equipment manufacturer that is one of the market leaders for residential energy storage.

The letter of intent was announced in June.

Electrovaya will supply the manufacturer its 48V Litastore battery modules. The supply agreement contains tiered volume and pricing, the company said.


Canexus Corp. (CUS-T)  says it board unanimously recommends shareholders reject the unsolicited takeover offer from Chemtrade Logistics Income Fund (CHE.UN-T).

Story continues below advertisement

"The Chemtrade offer does not represent full and fair value for Canexus," stated chairman Art Korpach in a release. "We have a strong ongoing business that is positioned to deliver increased value to shareholders. As demonstrated by past behaviour, your board is not opposed to a sale of the company as long as a sale reflects full and fair value for our assets and our growth potential. The Chemtrade offer simply doesn't do that."

Report an error Licensing Options
About the Author

Brenda Bouw is a freelance writer and editor based in Vancouver. She has more than 20 years of experience as a business reporter, including at The Globe and Mail, The Canadian Press, the Financial Post and was executive producer at BNN (formerly ROBTv). Brenda was also part of the Globe and Mail reporting team that won the 2010 National Newspaper Award for business journalism. More


The Globe invites you to share your views. Please stay on topic and be respectful to everyone. For more information on our commenting policies and how our community-based moderation works, please read our Community Guidelines and our Terms and Conditions.

We’ve made some technical updates to our commenting software. If you are experiencing any issues posting comments, simply log out and log back in.

Discussion loading… ✨